A handful of healthcare stocks are riding a wave of enthusiasm from artificial intelligence
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law.
For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.Shares of Recursion Pharmaceuticals, Schrodinger and others that are implementing AI are surging
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
'We were wrong' to write off stocks' AI-fueled rally, Morgan Stanley saysMorgan Stanley says it was wrong to write off stocks – but warns cooling inflation could still kill the rally
続きを読む »
Goldman upgrades this biotech, sees the shares doublingThe firm's price target implies shares could rally 117%.
続きを読む »
San Diego biotech Heron Therapeutics cuts 25% of workers, second corporate restructuring in a yearThe biotechnology company — which makes cancer and pain-management therapies — has not reached profitability and its new management is taking actions to reserve cash
続きを読む »
Breakingviews - Biotech’s doldrums are a warning amid exuberanceBiotechnology stocks have a tendency for the overdramatic, but they often pick up on economic trends early. So it’s worrying that Danaher , a supplier for drug firms, cut its annual revenue forecast on Tuesday in part because biotech companies are conserving capital. The sector’s doldrums are a warning sign, despite the broader market shrugging off recession concerns.
続きを読む »
Fueled by Super Bowl loss, Eagles’ Nick Sirianni is focused on ‘routine that produces the reward’The coach had a glimpse of the pinnacle in his sport, but he now understands the steps to climb that mountain are more important than ever.
続きを読む »
AMC had its highest ever app downloads, fueled by ‘Barbie’ and ‘Oppenheimer’“Barbie” and “Oppenheimer” have even sparked an internet phenomenon dubbed “Barbenheimer” with people watching both movies on the same day.
続きを読む »